Target intelligence / Profile preview

Family with sequence similarity 234 member A (FAM234A)

Target
FAM234A
Molecular classification
Other (transmembrane, predicted integrin-like protein but not a canonical receptor, enzyme, ion channel, or classical transporter)
01

Overview

Family with sequence similarity 234 member A (FAM234A), also referred to as Integrin alpha FG-GAP repeat containing 3 (ITFG3), is a serine- and leucine-rich human protein encoded by the FAM234A gene on chromosome 16p13.3[1][5][6]. The protein, predicted to be composed of 552 amino acids and approximately 59.7 kDa in size, is characterized by multiple transmembrane regions and is primarily localized to the endoplasmic reticulum, with some cellular presence at the ribosomes and nucleus[1][3][4]. FAM234A is highly conserved across vertebrates but is absent in single-celled organisms[1]. Expression is strong in tissues such as duodenum, adipose tissue, small intestine, and heart, although it appears in many human tissues[1][7]. The gene has multiple isoforms due to alternative splicing[1][9]. Its exact biological function is currently unknown, but genetic deletions (such as the "Newfoundland deletion") are associated with alpha-thalassemia phenotypes[1][2][5]. There is no evidence to classify FAM234A as a therapeutic target, nor are there known interacting drugs, mechanisms of drug action, or established biomarker or safety concern associations at present[5][3]. FAM234A is a member of a protein family defined by FG-GAP repeats, motifs typically involved in protein–protein interaction domains in integrins, but no specific function has been established for this protein in humans[2][8].

Other names
Protein FAM234AITFG3C16orf9DKFZP761D0211FLJ32603Protein ITFG3gs19Integrin alpha FG-GAP repeat containing 3
02

Biological functions

Unknown (exact function not characterized)Possible role in membrane organization or cell function due to transmembrane domains
03

Disease associations

Alpha-thalassemia (due to reported deletions)Other (potential, based on gene location; no clear disease mechanism established)

Beyond the preview

Go deeper on Family with sequence similarity 234 member A (FAM234A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Family with sequence similarity 234 member A (FAM234A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call